Abstract
Affinity therapy is the opportunity to attempt precise targeting of therapeutic effectors to their site of action. Within the past years, advances in biochemistry and molecular biology of membranes and cell growth regulation have provided tools that can assist in the design of more selective chemotherapeutic agents. Cloning and expressing genes coding for a variety of effector molecules allows the assembly of recombinant chimaeras for anticancer, immunosuppressive, antiviral and cardiovascular targeted therapy (Soria and Zeller, 1978; Soria and Martini, 1987; Soria, 1989a). Site-specific delivery might thus fulfil Paul Ehrlich’s dream of “magic bullets” by engineering specific structural/functional domains into therapeutic agents, in order to improve their persistence in the circulation and to localize them at the site of action.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bailon, P., Weber, D.V., Gately, M., Smart, J.E., Lorberboum-Galski, H., Fitzgerald, D., and Pastan, I., 1988, Purification and partial characterization of an Interleukin 2-Pseudomonas exotoxin fusion protein. Biotechnology 6:1326.
Benatti, L., Saccardo, B., Dani, M., Nitti, G., Sassano, M., Lorenzetti, R., Lappi, D.A. and Soria, M., 1989, Molecular cloning and characterization of the gene coding for a ribosome inactivating protein from the leaves of Saponaria officinalis, Eur.J.Biochem., 183:465.
Blasi, F., 1988, Surface receptors for urokinase plasminogen activators. Fibrinolysis, 2:73.
Boer, P.H. and Gray, M.W., 1988, Scrambled ribosomal RNA gene pieces in Chlamidomonas reinhardtii mitochondrial DNA, Cell, 55:399.
Bressan, G.M. and Stanley, K.K., 1987, PUEX, a bacterial expression vector related to PEX with univeral host specificity, Niicl.Acids Res., 15:10056.
Case, J.P., Lorberboum-Galski, H., Lafyatis, R., Fitzgerald, D., Wilder, R.L. and Pastan, I., 1989, Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats, Proc.Natl.Acad.Sci. USA, 86:287.
Chaudhary, V.K., Fitzgerald, D.J., Adhya, S. and Pastan, I., 1987, Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas exotoxin, Pr oc. Natl. Acad. Sci. USA, 85:4538.
Chaudhary, V.K., Mizukami, T., Fuerst, T.R., Fitzgerald, D.J., Moss, B., Pastan, I. and Berger, E.A., 1988, Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein, Nature, 335:369.
Chaudhary, V.K., Queen, C, Junghans, R.P., Waldmann, T.A., Fitzgerald, D.J. and Pastan, I., 1989, A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature, 339:394.
Danilov, Y.N. and Juliano, R.L., 1989, (Arg-Gly-Asp)n-albumin conjugates as a model substratum for integrin-mediated cell adhesion, Exp. Cell Res., 182:186.
Dodd, J. and Jessell, T.M., 1988, Axon guidance and the patterning of neuronal projections in vertebrates. Science, 242:692.
Eul, J., Meyer, M.E., Tora, L., Bocquel, M.T., Quirin-Stricker, C., Chambon, P. and Gronemeyer, H., 1989, Expression of active hormone and DNA- binding domains of the chicken progesterone receptor in E.Coli, EMBO J. 8:83.
Gilbert, W., 1978, Why genes in pieces?. Nature, 271:501.
Goldfarb, D.S., Gariepy, J. and Romberg, R.D., 1986, Synthetic peptides as nuclear localization signals, Nature, 322:641.
Gronemeyer, H., 1988, Affinity labelling and cloning of steroid and thyroid hormone receptors: techniques, application and functional analysis, Ellis Horwood, New York.
Habuka, N., Murakami, Y., Noma, M., Kudo, T. and Horikoshi, K., 1989, Amino acid sequence of Mirabilis antiviral protein, total s5nithesis of its gene and expression in E. coli, J.Biol.Chem., 264:6629.
Kaneda, Y., Iwai, K. and Uchida, T., 1989a, Introduction and expression of the human insulin gene in adult rat liver, J.Biol.Chem., in press.
Kaneda, Y., Iwai, K. and Uchida, T., 1989b, Increased expression of DNA co- introduced with nuclear protein in adult rat liver. Science, 243:375.
Kanno, H., Huang, I-Y, Kan, Y.W. and Yoshida, A., 1989, Two structural genes on different chromosomes are required for encoding the major subunit of human red cell glucose 6-phosphate dehydrogenase. Cell, 58:595.
Kelley, V.E., Bacha, P., Pankewycz, O., Nichols, J.C., Murphy, J.R. and Strom, T.B., 1988, Interleiikin 2-diphtheria toxin fusion protein can abolish cell-mediated iinimmity in vivo, Proc.Nat.Acad.Sci.USA, 85:3980.
Kim, J. and Weaver, R.F., 1988, Construction of a recombinant expression Plasmid encoding a staphylococcal protein A-ricin A fusion protein. Gene, 68:315.
Lanford, R.E., Kanda, P. and Kennedy, R.C., 1986, Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell, 46:575.
Latta, M., Knapp, M., Sarmientos, P., Brefort, G., Becquart, J., Guerrier, L., Jung, G. and Mayaux, J.F., 1987, Sthesis and purification of mature serum albumin from E. coli, Biotechnol. 5:1309.
Levi, S., Cesareni, G., Arosio, P., Lorenzetti, R., Soria, M., Sollazzo, M., Albertini, A. and Cortese, R., 1987, Characterization of human ferritin H chain synthesized in E. coli. Gene, 51:269.
Lorberboum-Galski, H., FitzGerald, D., Chaudhary, V.K., Adhya, S. and Pastan, I., 1988, Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli, Proc.Nat. Acad.Sci.USA, 85:1922.
Lorberboum-Galski, H., Barrett, L.V., Kirkman, R.L., Ogata, M., Willingham, M.C., Fitzgerald, D.J. and Pastan, I., 1989, Cardiac allograft in mice treated with IL2-PE40, Proc.Nat 1.Acad. Sei.USA, 86:1008.
Lorenzetti, R., Benatti, L., Dani, M., Lappi, D.A., Saceardo, B.M. and Soria, M., 1988, Nucleotide sequence encoding plant ribosome- inaetivating protein, Brit, Pat. Appl. n. 880:877.
Luzzago, A. and Cesareni, G., 1989, Isolation of point mutations that affect the folding of the H chain of human ferritin in E. coli, EMBO J., 8:569.
Marullo, S., Delavier-Klutchko, C., Eshdat, Y., Strosberg, A.D. and Bmrine, L.J., 1988, Human beta2-adrenergic receptors expressed in E. coli retain their pharmacological properties, Proc.Natl.Acad.Sci.USA 85:7551.
Marullo, S., Delavier-Klutchko, C., Guillet, J-G., Charbit, A., Strosberg, A.D. and Eraorine, L.J., 1989, Expression of human beta 1 and beta 2 adrenergic receptors in E. coli as a new tool for ligand screening, Biotechnol., 7:923.
Murphy, R.J., Bishai, W., Borowski, M., Miyanohara, A., Boyd, J. and Nagle, S., 1986, Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related gamma-melanocyte- stimulating hormone fusion protein, Proc.Nat 1.Acad. Sci.USA, 83:8258.
Tieyer, D.D. and Forbes, D.J., 1988, Nuclear import can be separated into distinct steps in vitro: nuclear pore binding and translocation. Cell, 52:641.
Ogata, M., Chaudhary, V.K., Fitzgerald, D.K. and Pastan, I., 1989, Cytotoxic activity of a recombinant fusion protein between interleukin A and Pseudomonas exotoxin, Proc.Nat 1.Acad.Sci.USA, 86:4215.
Patthy, L., 1985, Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modiiles. Cell, 41:657.
Schlegel, R. and Wade, M., 1984, A synthetic peptide corresponding to the NH2 terminus of vesicular stomatitis virus glycoprotein is a pH- dependent hemolysin, J.Biol.Chem., 259:4691.
Scott, J., 1989, Thrombogenesis linked to atherogenesis at last? Natxire, 341:22.
Siegall, C.B., Chaudhary, V.K., Fitzgerald, D.J. and Pastan, I., 1988, Cytotoxic activity of an interleiikin 6-Pseudomonas exotoxin fusion protein on human myeloma cells, Proc.Natl.Acad.Sci.USA, 85:9738.
Soria, M., 1989a, Molecular targeting and delivery: applications of recombinant DNA technology, Biotechnol.Appl.Biochem., in press.
Soria, M., 1989b, Immunotoxins, ligand-toxin conjugates and molecular targeting, Pharmacol. Res., in press.
Soria, M. and Martini, D., 1987, Recombinant strategies in the search for targeted pharmaceuticals, in: Proc. 4th European Congress on Biotechnology, Vol. 4, O.M. Neijssel, R.R. Van der Meer and K.Ch.A.M. Luyben, eds., Elsevier, Amsterdam.
Soria, M. and Zeller, L., 1978, Expectations and priorities of pharmaceutical industry, in: “Genetic Engineering: Scientific Discoveries and Practical Applications”, H. Boyer and S. Nicosia, eds., Elsevier, Amsterdam.
Stegmann, T., Doms, R.W. and Helenius, A., 1989, Protein-mediated membrane fusion, Ann.Rev.Biophys.Chem., 18:187.
Williams, D.P., Parker, K., Bacha, P., Bishai, W., Borowski, M., Genbauffe, F., Strom, T.B. and Murphy, J.R., 1987, Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein, Prot.En, 1:493.
Yoneda, Y., Imamoto-Sonobe, N., Matsuoka, Y., Iwamoto, R., Kiho, Y. and Uchida, T., 1988, Antibodies to Asp-Asp-Glu-Asp can inhibit transport of nuclear proteins into the nucleus. Science, 242:275.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Soria, M. (1990). Recombinant Ligand-Toxin Conjugates, Domain Engineering and the Search for Targeted Pharmaceuticals. In: Gregoriadis, G., Allison, A.C., Poste, G. (eds) Targeting of Drugs 2. NATO ASI Series, vol 199. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-9001-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9001-5_2
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-9003-9
Online ISBN: 978-1-4684-9001-5
eBook Packages: Springer Book Archive